Acylhydrazone derivatives: a patent review

Bibliography

• Duarte CD, Barreiro EJ, Fraga CAM. Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem 2007;7:1108-19
   PubMed Web of Science ®Google Scholar
• Krause T, Gerbershagen MU, Fiege M, et al. Dantrolene–a review of its pharmacology, therapeutic use and new developments. Anaesthesia 2004;59:364-73
   PubMed Web of Science ®Google Scholar
• Ribeiro IG, Silva KCM, Parrini SC, et al. Synthesis and antinociceptive properties of new structurally planned imidazo[1,2-a]pyridine 3-acylarylhydrazone derivatives. Eur J Med Chem 1998;33:225-35
   Google Scholar
• Lima PC, Lima LM, Silva KCM, et al. Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole. Eur J Med Chem 2000;35:187-203
   PubMed Web of Science ®Google Scholar
• Figueiredo JM, Câmara CA, Amarante EG, et al. Design and synthesis of novel potent antinociceptive agents: methyl-imidazolyl N-acylhydrazone derivatives. Bioorg Med Chem 2000;8:2243-8
   PubMedGoogle Scholar
• Bhat VT, Caniard AM, Luksch T, et al. Nucleophilic catalysis of acylhydrazone equilibration for protein-directed dynamic covalent chemistry. Nat Chem 2010;2:490-7
   PubMed Web of Science ®Google Scholar
• Andrade MM, Barros MT. Fast synthesis of N-acylhydrazones employing a microwave assisted neat protocol. J Comb Chem 2010;12:245-7
   PubMedGoogle Scholar
• Nascimento NM Jr, Kummerle AE, Barreiro EJ, Fraga CAM. MAOS and medicinal chemistry: some important examples from the last years. Molecules 2011;16:9274-97
   PubMed Web of Science ®Google Scholar
• Su X, Aprahamian I. Hydrazone-based switches, metallo-assemblies and sensors. Chem Soc Rev 2014;43:1963-81
   PubMed Web of Science ®Google Scholar
• Pol-Fachin L, Fraga CAM, Barreiro EJ, Verli H. Characterization of the conformational ensemble from bioactive N-acylhydrazone derivatives. J Mol Graph Model 2010;28:446-54
   PubMedGoogle Scholar
• Kummerle AE, Raimundo JM, Leal CM, et al. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives. Eur J Med Chem 2009;44:4004-9
   PubMed Web of Science ®Google Scholar
• Lopes AB, Miguez E, Kummerle AE, et al. Characterization of amide bond conformers for a novel heterocyclic template of N-acylhydrazone derivatives. Molecules 2013;18:11683-704
   PubMed Web of Science ®Google Scholar
• Barreiro EJ, Kümmerle AE, Fraga CAM. The methylation effect in medicinal chemistry. Chem Rev 2011;111:5215-46
   PubMed Web of Science ®Google Scholar
• Palla G, Pelizzi C, Predieri G, Vignali C. Conformational study on N-acylhydrazones of aromatic aldehydes by NMR-spectroscopy. Gazz Chim Ital 1982;112:339-41
   Google Scholar
• Tributino JLM, Duarte CD, Corrêa RS, et al. Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidates. Bioorg Med Chem 2009;17:1125-31
   PubMedGoogle Scholar
• Ifa DR, Rodrigues CR, Alencastro RB, et al. A possible molecular mechanism for the inhibition of cysteine proteases by salicylaldehyde N-acylhydrazones and related compounds. J Mol Struct Theochem 2000;505:11-17
   Google Scholar
• He JB, Feng LL, Li J, et al. Design, synthesis and molecular modeling of novel N-acylhydrazone derivatives as pyruvate dehydrogenase complex E1 inhibitors. Bioorg Med Chem 2014;22:89-94
   PubMedGoogle Scholar
• Zhai X, Huang Q, Jiang N, et al. Discovery of hybrid dual N-acylhydrazone and diaryl urea derivatives as potent antitumor agents: design, synthesis and cytotoxicity evaluation. Molecules 2013;18:2904-23
   PubMed Web of Science ®Google Scholar
• Zhang D, Ma Y, Liu Y, Liu Z-P. Synthesis of sulfonylhydrazone- and acylhydrazone-Substituted 8-ethoxy-3-nitro-2H-chromenes as potent antiproliferative and apoptosis inducing agents. Arch Pharm 2014;347:1-13
   PubMedGoogle Scholar
• Amaral DN, Cavalcanti BC, Bezerra DP, et al. Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues. PLoS One 2014;9:e85380
   Google Scholar
• Carvalho SA, Feitosa LO, Soares M, et al. Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents. Eur J Med Chem 2012;54:512-21
   PubMedGoogle Scholar
• Rodrigues APC, Costa LM, Santos BLR, et al. Novel furfurylidene N-acylhydrazones derived from natural safrole: discovery of LASSBio-1215, a new potent antiplatelet prototype. J Enzyme Inhib Med Chem 2011;27:101-9
   PubMedGoogle Scholar
• Brito FCF, Kummerle AE, Lugnier C, et al. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition. Eur J Pharmacol 2010;638:5-12
   PubMed Web of Science ®Google Scholar
• Kummerle AE, Vieira MM, Schmitt M, et al. Design, synthesis and analgesic properties of novel conformationally-restricted N-acylhydrazones (NAH). Bioorg Med Chem Lett 2009;19:4963-6
   PubMed Web of Science ®Google Scholar
• Hernández P, Cabrera M, Lavaggi ML, et al. Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives. Bioorg Med Chem 2012;20:2158-71
   PubMed Web of Science ®Google Scholar
• Khalil NA, Ahmed EM, Mohamed KO, Zaitone SA. Synthesis of new nicotinic acid derivatives and their evaluation as analgesic and anti-inflammatory agents. Chem Pharm Bull 2013;61:933-40
   PubMedGoogle Scholar
• Lacerda RB, daSilva LL, deLima CKF, et al. Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-alpha production. PLoS One 2012;7:e46925
   PubMed Web of Science ®Google Scholar
• Lacerda RB, Sales NM, daSilva LL, et al. Novel potent imidazo[1,2-a]pyridine-N-glycinyl-hydrazone inhibitors of TNF-alpha production: in vitro and in vivo studies. PLoS One 2014;9:e91660
   Google Scholar
• Avila CM, Lopes AB, Gonçalves AS, et al. Structure-based design and biological profile of (E)-N-(4-nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-beta. Eur J Med Chem 2011;46:1245-53
   PubMed Web of Science ®Google Scholar
• Zapata-Sudo G, Pereira SL, Beiral HJ, et al. Pharmacological characterization of (3-thienylidene)-3,4-methylenedioxybenzoylhydrazide: a novel muscarinic agonist with antihypertensive profile. Am J Hypertens 2010;23:135-41
   PubMedGoogle Scholar
• Leal CM, Pereira SL, Kümmerle AE, et al. Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor. Eur J Med Chem 2012;55:49-57
   PubMedGoogle Scholar
• Costa DG, da Silva JS, Kümmerle AE, et al. LASSBio-294, a compound with inotropic and lusitropic activity, decreases cardiac remodeling and improves Ca2+ influx into sarcoplasmic reticulum after myocardial infarction. Am J Hypertens 2010;23:1220-7
   PubMedGoogle Scholar
• Alencar AK, Pereira SL, Montagnoli TL, et al. Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats. Br J Pharmacol 2013;169:953-62
   PubMedGoogle Scholar
• Gonzalez-Serratos H, Chang R, Pereira EF, et al. A novel thienylhydrazone, (2-thienylidene)3,4-methylenedioxybenzoylhydrazine, increases inotropism and decreases fatigue of skeletal muscle. J Pharmacol Exp Ther 2001;299:558-66
   PubMed Web of Science ®Google Scholar
• Sudo RT, Zapata-Sudo G, Barreiro EJ. The new compound, LASSBio 294, increases the contractility of intact and saponin-skinned cardiac muscle from Wistar rats. Br J Pharmacol 2001;134:603-13
   PubMedGoogle Scholar
• Zapata-Sudo G, Sudo RT, Maronas PA, et al. Thienylhydrazone derivative increases sarcoplasmic reticulum Ca2+ release in mammalian skeletal muscle. Eur J Pharmacol 2003;470:79-8
   PubMedGoogle Scholar
• Espacenet. Available from: www.epo.org/searching/free/espacenet.htm [Accessed in 20 – 28 February 2014]
   Google Scholar
• Delphion. Available from: www.delphion.com/ [Accessed in 20 – 28 February 2014]
   Google Scholar
• Bayer AG. Quinonoxime-acylhydrazone derivatives their preparation and their use as fungicides. DE2410184; 1975
   Google Scholar
• Sumitomo Chemical Co. A process for preparing novel acylhydrazone derivatives and their salts. JPS51125087; 1976
   Google Scholar
• Antibiotice Iasi Intreprindere. Water-soluble rifamycin derivatives and processes for their preparation. CH638530; 1983
   Google Scholar
• Merck & Co. 5-oxime avermectin derivatives. US5015630; 1991
   Google Scholar
• Bristol-Myers Squibb Co. Anthracycline conjugates having a novel linker and methods for their production. US5122368; 1992
   Google Scholar
• Bristol-Myers Squibb Co. Thioether conjugates. US5622929; 1997
   Google Scholar
• University of Maryland/Universidade Federal do Rio de Janeiro. Thienylhydrazon with digitalis-like properties (positive inotropic effects). US7091238; 2006
   Google Scholar
• Universidade Federal do Rio de Janeiro – UFRJ. Anti-inflammatory and analgesic pharmaceutical composition containing safrole N-acylhydrazone derivatives, use, and method of preparation. WO2007131310; 2007
   Google Scholar
• Gericke Rolf & col. Acylhydrazone derivatives and the use thereof in the inhibition, regulation and/or modulation of kinase signal transduction. US2008214674; 2008
   Google Scholar
• Neurosearch AS. N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors. US2010280092; 2010
   Google Scholar
• Neurosearch AS. N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors. US2010292334; 2010
   Google Scholar
• Universidade Federal do Rio de Janeiro – UFRJ. Dérivés N-acylhydrazoniques, procédé de production de composés n-acylhydrazoniques, compositions pharmaceutiques les contenant, utilisations de ceux-ci et méthodes de traitement. WO2010043010; 2010
   Google Scholar
• Liaocheng University. Acylhydrazone Schiff alkali compound and preparation method and application thereof. CN102060757; 2011
   Google Scholar
• Liaocheng University. Acylhydrazone Schiff alkaline compound and preparation method and application thereof. CN102060759; 2011
   Google Scholar
• Hefei University of Technology. Compound with anticancer activity and preparation method thereof. CN102603619; 2012
   Google Scholar
• Nanjing University. Vanillic acid acylhydrazone derivatives, and preparation method and application thereof. CN103044284; 2013
   Google Scholar
• Nanjing University. Preparation of pyrazole-acylhydrazone compounds and application of pyrazole-acylhydrazone compounds in anticancer treatment. CN103086972; 2013
   Google Scholar
• Guangxi University of Chinese Medicine. Alpha-glycosidase inhibitor preparation method and purpose. CN103159755; 2013
   Google Scholar
• Nanjing University. 1,2,4-Triazole and pyrazine ring-containing acylhydrazone derivatives, preparation method and applications. CN103373988; 2013
   Google Scholar
• Nanjing University. 1,3,4-Oxadiazole and pyridine (pyrazine) ring-containing acylhydrazone derivatives, preparation method and applications. CN103373992; 2013
   Google Scholar
• Universidade Federal do Rio de Janeiro – UFRJ. Heterocyclic N-glycinyl-N-acylhydrazone compounds, synthesis method, pharmaceutical compositions and treatment method. WO2013078523; 2013
   Google Scholar
• Universidade Federal do Rio de Janeiro – UFRJ. Hydrazide-n-acylhydrazone compounds, method for producing hydrazide-N-acylhydrazone compounds, use of intermediate compounds for producing hydrazide-n-acylhydrazones fof the treatment of leishmaniasis and chagas disease, and thus obtained pharmaceutical compositions. WO2014019044; 2014
   Google Scholar